CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

Recently published research shows that a medical device may be beneficial for patients who have previously had a stroke and are planning to undergo a transcatheter aortic valve replacement, a type of ...

Higher TAVI procedure volumes are associated with a greater likelihood of using an embolic protection device, data from more than 500 US hospitals show. The authors undertook the study expecting to ...

Please provide your email address to receive an email when new articles are posted on . Adults who underwent transcatheter aortic valve replacement with a cerebral protection system experienced fewer ...

Please provide your email address to receive an email when new articles are posted on . The Emboliner embolic protection device showed noninferiority vs. the Sentinel device during TAVR. The new ...

Using cerebral embolic protection devices during transcatheter aortic valve implantation (TAVI) procedures does not reduce a patient's risk of experiencing a stroke, according to a large UK clinical ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

LONDON — Two years after the large multinational PROTECTED TAVR trial failed to associate a cerebral embolic protection (CEP) device with significant protection from stroke in patients undergoing ...

CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...

Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

Elective carotid artery angioplasty and stenting was initiated in the United States in 1994 by the endovascular interventional team at the University of Alabama at Birmingham. Carotid stenting was ...